Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
The Oncologist
|
October 26, 2020
A Phase I Open-Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26-104/RFASE in Patients with Advanced Solid Malignancies
Ruben S A Goedegebuure, Madelon Q Wentink, Hans J van der Vliet, et al.
The Journal of Biological Chemistry
|
October 8, 2009
A combinatorial approach for the design of complementarity-determining region-derived peptidomimetics with in vitro anti-tumoral activity
Peter Timmerman, Rodrigo Barderas, Johan Desmet, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2016
Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity
Madelon Q Wentink, Tilman M Hackeng, Sebastien P Tabruyn, et al.
ACS Chemical Biology
|
October 29, 2025
Chemokine-Binding All-D-CLIPS Peptides Identified Using Mirror-Image Phage Display
Stepan S Denisov, Emilia L Bialek, Fabio Beretta, et al.
Molecular Diversity
|
June 24, 2004
Mapping of a discontinuous and highly conformational binding site on follicle stimulating hormone subunit-beta (FSH-beta) using domain Scan and Matrix Scan technology
Peter Timmerman, Evert Van Dijk, Wouter Puijk, et al.
The Journal of Physical Chemistry. B
|
September 21, 2013
Folding dynamics of the Trp-cage miniprotein: evidence for a native-like intermediate from combined time-resolved vibrational spectroscopy and molecular dynamics simulations
Heleen Meuzelaar, Kristen A Marino, Adriana Huerta-Viga, et al.
Biomolecules
|
June 24, 2022
Molecular Detection of Venous Thrombosis in Mouse Models Using SPECT/CT
Annemiek Dickhout, Pieter Van de Vijver, Nicole Bitsch, et al.
Blood
|
March 30, 2011
Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies
Gerhard Niederfellner, Alfred Lammens, Olaf Mundigl, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
The Oncologist
|
October 26, 2020
A Phase I Open-Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26-104/RFASE in Patients with Advanced Solid Malignancies
Ruben S A Goedegebuure, Madelon Q Wentink, Hans J van der Vliet, et al.
The Journal of Biological Chemistry
|
October 8, 2009
A combinatorial approach for the design of complementarity-determining region-derived peptidomimetics with in vitro anti-tumoral activity
Peter Timmerman, Rodrigo Barderas, Johan Desmet, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2016
Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity
Madelon Q Wentink, Tilman M Hackeng, Sebastien P Tabruyn, et al.
ACS Chemical Biology
|
October 29, 2025
Chemokine-Binding All-D-CLIPS Peptides Identified Using Mirror-Image Phage Display
Stepan S Denisov, Emilia L Bialek, Fabio Beretta, et al.
Molecular Diversity
|
June 24, 2004
Mapping of a discontinuous and highly conformational binding site on follicle stimulating hormone subunit-beta (FSH-beta) using domain Scan and Matrix Scan technology
Peter Timmerman, Evert Van Dijk, Wouter Puijk, et al.
The Journal of Physical Chemistry. B
|
September 21, 2013
Folding dynamics of the Trp-cage miniprotein: evidence for a native-like intermediate from combined time-resolved vibrational spectroscopy and molecular dynamics simulations
Heleen Meuzelaar, Kristen A Marino, Adriana Huerta-Viga, et al.
Biomolecules
|
June 24, 2022
Molecular Detection of Venous Thrombosis in Mouse Models Using SPECT/CT
Annemiek Dickhout, Pieter Van de Vijver, Nicole Bitsch, et al.
Blood
|
March 30, 2011
Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies
Gerhard Niederfellner, Alfred Lammens, Olaf Mundigl, et al.
Page
of 5